U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358975) titled 'Prediction of Complications in Hepatic Tumors' on Dec. 05, 2025.
Brief Summary: Liver failure is one of the most severe complications in patients undergoing liver surgery for hepatic malignancies. However, it can be predicted through preoperative assessment of liver function. Technetium-99m galactosyl human serum albumin ([99mTc] Tc-GSA), combined with single-photon emission computed tomography fused with computed tomography ([99mTc] Tc-GSA SPECT/CT), is widely used in Asia due to its superiority in predicting postoperative liver failure. Unfortunately, its clinical use in Western countries remains limited due to concerns about dise...